Ultradiol was established with a shared team mission of providing an exceptionally crafted CBD product for distribution through professional networks of healthcare practitioners. Beyond our individual advocacy for CBD and our support for thorough research into its therapeutic values, we were acutely aware of the current state of the CBD market – it’s overpopulated with product but scant on quality.
With the proliferation of cannabis therapies, products claiming to be CBD are a dime a dozen. Those who seek to use CBD for its reported therapeutic benefits are overwhelmingly under-informed as to how to determine the quality of an individual CBD product. Further to sifting through thousands of options, which is an undertaking in and of itself, prospective buyers are not provided sufficient guidelines to vet a product before purchasing. This can be largely attributed to the fact that the market remains unregulated by agencies (such as the FDA) due to industrial hemp’s classification under the Controlled Substances Act. Without rigorous requirements in place for manufacturing and quality control, independent testing, unit-dosing, compliant packaging, etc., the market runs amok with deceptive products and unhappy customers.
With Ultradiol now available nationwide through healthcare professionals, patients can feel confident they are taking a physician preferred product that is safe, effective and valuable.